Nx GEN SEQUENCING DEMENTIA Test – DNA Labs UAE
Are you concerned about dementia? DNA Labs UAE offers the Nx GEN SEQUENCING DEMENTIA Test, a cutting-edge genetic test that can provide valuable insights into the genetic basis of dementia. In this blog post, we will discuss the test components, cost, sample condition, report delivery, method, and more.
Test Details
The Nx GEN SEQUENCING DEMENTIA Test utilizes Next-generation sequencing (NGS), a high-throughput DNA sequencing technology. NGS allows for the rapid and efficient analysis of large amounts of genetic information, revolutionizing the field of genomics. This advanced technology has applications in disease diagnostics and personalized medicine.
When it comes to dementia, NGS can be used to identify genetic variations and mutations associated with the disease. By sequencing the entire genome or specific regions of interest, researchers can analyze the genetic makeup of individuals and compare it to known genetic markers for dementia. NGS can help identify rare genetic variants that may contribute to an individual’s risk of developing dementia.
NGS is particularly useful in identifying genetic mutations responsible for inherited forms of dementia, such as familial Alzheimer’s disease or frontotemporal dementia. Additionally, NGS can study the role of epigenetic modifications in dementia. Epigenetic changes, like DNA methylation or histone modifications, can influence gene expression and have been implicated in neurological disorders, including dementia. NGS provides a comprehensive view of the epigenome and helps identify specific epigenetic changes associated with dementia.
Overall, NGS holds great promise in advancing our understanding of the genetic basis of dementia. It may eventually lead to the development of more accurate diagnostic tests and targeted therapies for this devastating disease.
Test Components
The Nx GEN SEQUENCING DEMENTIA Test analyzes the following genetic components:
- APOE
- APP
- CHMP2B
- CSF1R
- FUS
- GRN
- MAPT
- PRNP
- PSEN1
- PSEN2
- SORL1
- TARDBP
- TREM2
- UBE3A
- VCP
Price
The cost of the Nx GEN SEQUENCING DEMENTIA Test is 4680.0 AED.
Sample Condition
To perform the test, you need to submit 10 mL (5 mL minimum) of whole blood from 2 Lavender Top (EDTA) tubes. It is essential to ship the sample refrigerated and avoid freezing it. Additionally, a duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery
The sample is collected daily by 9 am, and the report will be delivered within 40 working days.
Method
The Nx GEN SEQUENCING DEMENTIA Test utilizes Next-generation sequencing (NGS) and Sanger sequencing methods to analyze the genetic information.
Test Type
The Nx GEN SEQUENCING DEMENTIA Test falls under the category of Genetic Disorders-Dementia.
Doctor and Test Department
The test is recommended by neurologists and falls under the Molecular Diagnostics department.
Pre Test Information
Before taking the Nx GEN SEQUENCING DEMENTIA Test, it is mandatory to fill out the Whole Exome Sequencing Consent Form (Form 37).
Take control of your health and gain valuable insights into the genetic basis of dementia with the Nx GEN SEQUENCING DEMENTIA Test offered by DNA Labs UAE. Stay informed and make informed decisions about your well-being.
Test Name | Nx GEN SEQUENCING DEMENTIA Test |
---|---|
Components | APOE, APP, CHMP2B, CSF1R, FUS, GRN, MAPT, PRNP, PSEN1, PSEN2, SORL1, TARDBP, TREM2, UBE3A, VCP |
Price | 4680.0 AED |
Sample Condition | Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. |
Report Delivery | Sample Daily by 9 am; Report 40 Working days |
Method | NGS, Sanger sequencing |
Test type | Genetic Disorders-Dementia |
Doctor | Neurologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. |
Test Details |
Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that allows for the rapid and efficient analysis of large amounts of genetic information. It has revolutionized the field of genomics and has applications in various areas, including disease diagnostics and personalized medicine. When it comes to dementia, NGS can be used to identify genetic variations and mutations that may be associated with the disease. By sequencing the entire genome or specific regions of interest, researchers can analyze the genetic makeup of individuals and compare it to known genetic markers for dementia. NGS can help identify rare genetic variants that may contribute to an individual’s risk of developing dementia. It can also aid in the identification of genetic mutations that may be responsible for inherited forms of dementia, such as familial Alzheimer’s disease or frontotemporal dementia. Furthermore, NGS can be used to study the role of epigenetic modifications in dementia. Epigenetic changes, such as DNA methylation or histone modifications, can influence gene expression and have been implicated in various neurological disorders, including dementia. NGS can provide a comprehensive view of the epigenome and help identify specific epigenetic changes associated with dementia. Overall, NGS holds great promise in advancing our understanding of the genetic basis of dementia and may eventually lead to the development of more accurate diagnostic tests and targeted therapies for this devastating disease. |